The 1858 C/T SNP of the PTPN22 gene is a risk factor for HT because it causes an arginine-tryptophan substitution at codon 620 (R620W), because decreased T cell signaling may results in poorer thymic elimination of autoreactive T cells, or an increased function of PTPN22 may lead to a decrease in regulatory T cells (Tregs) responsible for preventing autoimmunity
Despite the new class of GLP-1 agonists, there remain only 5 FDA-approved medications to treat obesity, highlighting a clear need for additional pharmacotherapy
The initiative, announced by the Centers for Medicare & Medicaid Services, or CMS, is a short-term pilot program known as the Medicare GLP-1 Bridge
A Certificate of Analysis (COA) is available for each batch upon request, documenting identity, purity, copper content, and sterility metrics
Gastrointestinal inflammation and associated immune activation in schizophrenia
Diabetologia 67 , 528546 (2024)